These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6402675)

  • 21. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vindesine-associated angina and ECG changes.
    Yancey RS; Talpaz M
    Cancer Treat Rep; 1982 Mar; 66(3):587-9. PubMed ID: 7060049
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase II trial of vindesine in advanced head and neck cancer.
    Cheng E; Young CW; Wittes RE
    Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Possibilities of nonspecific immunotherapy with BCG in malignant melanomas of the skin].
    Romano S; Ziccardi M; Muzio GF; Filippi B
    Arch Maragliano Patol Clin; 1976; 32():114-21. PubMed ID: 802769
    [No Abstract]   [Full Text] [Related]  

  • 25. A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma.
    Bedikian AY; Papadopoulos NE; Kim KB; Vardeleon A; Smith T; Lu B; Deitcher SR
    Melanoma Res; 2008 Dec; 18(6):400-4. PubMed ID: 19011511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of in vitro chemosensitivity testing in malignant melanoma.
    MacKie RM; Gaukroger JM; Wilson L
    Lancet; 1983 Mar; 1(8324):587-8. PubMed ID: 6131278
    [No Abstract]   [Full Text] [Related]  

  • 27. A phase II study of neoadjuvant biochemotherapy for stage III melanoma.
    Gibbs P; Anderson C; Pearlman N; LaClaire S; Becker M; Gatlin K; O'Driscoll M; Stephens J; Gonzalez R
    Cancer; 2002 Jan; 94(2):470-6. PubMed ID: 11900232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.
    Eigentler TK; Radny P; Hauschild A; Gutzmer R; Linse R; Pföhler C; Wagner SN; Schadendorf D; Ellwanger U; Garbe C;
    Melanoma Res; 2008 Oct; 18(5):353-8. PubMed ID: 18781134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
    Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
    Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alternative treatment with carmustine, vindesine and tamoxifen in previously cytostaticly (VAC, FMC) treated patients with metastatic breast cancer].
    Massner B; Voss I; Queisser W; Drings P; Fritze D; Westerhausen M
    Onkologie; 1982 Aug; 5 Suppl():46-51. PubMed ID: 6752791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
    Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
    Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of vindesine in patients with Hodgkin's disease, lymphoma, and breast cancer.
    Gad-El-Mawla N; Hamza MR; El-Serafi M; El-Khoudary A; Aboul-Einein M; El-Demerdash S
    Cancer Treat Rep; 1983 Mar; 67(3):316-7. PubMed ID: 6831481
    [No Abstract]   [Full Text] [Related]  

  • 33. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
    Rudolf Z; Strojan P
    Neoplasma; 1996; 43(2):93-7. PubMed ID: 8843969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies with sorafenib (Nexavar) in metastatic melanoma].
    Hauschild A
    J Dtsch Dermatol Ges; 2007 Apr; 5(4):345. PubMed ID: 17376105
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current treatment of skin melanomas].
    Navarra S; Melita P; Barbuscia M; Calbo L; Belnome NA
    Minerva Chir; 1982 Mar; 37(5):375-84. PubMed ID: 7045727
    [No Abstract]   [Full Text] [Related]  

  • 36. A phase II study of bortezomib in the treatment of metastatic malignant melanoma.
    Markovic SN; Geyer SM; Dawkins F; Sharfman W; Albertini M; Maples W; Fracasso PM; Fitch T; Lorusso P; Adjei AA; Erlichman C
    Cancer; 2005 Jun; 103(12):2584-9. PubMed ID: 15887220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitoxantrone in malignant melanoma.
    Presant CA; Gams R; Bartolucci A
    Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma.
    Göring HD; Zierner A; Kröning Y; Trebing D; Kämpgen E; Bröcker EB
    Melanoma Res; 1998 Aug; 8(4):379. PubMed ID: 9764815
    [No Abstract]   [Full Text] [Related]  

  • 39. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
    Luedke SL; Luedke DW; Petruska P; Broun GO; Reed G; Leavitt J
    Cancer Treat Rep; 1982 Jun; 66(6):1409-11. PubMed ID: 7083243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?
    Koomen ER; Joosse A; Herings RM; Casparie MK; Bergman W; Nijsten T; Guchelaar HJ
    Eur J Cancer; 2007 Nov; 43(17):2580-9. PubMed ID: 17950596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.